“Rejected” Cure STOPS Alzheimer’s Disease

You know the saying, “Too much of a good thing.”

That applies perfectly to a controversial Alzheimer’s treatment.

In the past, the mainstream rejected it because it works for psychiatric issues… and can have some long term health effects when given in a “therapeutic” doses.

But a recent study showed that these doses are too high.

Instead, a minuscule dose – 400 times LOWER than the standard – is not only safe… but it could STOP Alzheimer’s in its tracks.

The search continues for an outright cure for Alzheimer’s disease.

In the meantime, anyone dealing with the disease would settle for a way to slow its progression.

A study just published in the Journal of Alzheimer’s Disease has uncovered a pretty surprising way to do just that.

Conventional medicine uses lithium to treat mental disorders like bipolar and depression.

But many studies looking into its benefits for Alzheimer’s disease are considered controversial and inconclusive.  And taking high doses of lithium long term can cause serious adverse effects.

But in a surprising new study, researchers found that using lithium at a dose 400 times lower than the dose used to treat mood disorders can safely STOP Alzheimer’s in its tracks.

Giving these micro-doses to rats with Alzheimer’s disease had two impressive effects:

• First, it stopped the formation of the amyloid plaques that are the root cause of the disease.
• Second, it helped to recover lost cognitive abilities.

The reason such a low dose still works is that it’s given in a form that delivers it directly to the brain while minimizing the amount of lithium in the blood.

This unique delivery method helps prevent the potential side effects of having the lithium where it’s NOT needed… and allows it to go straight to the brain, where it can work its magic.

The results were so encouraging that the researchers believe that lithium has “immediate therapeutic applications,” and saying that micro-doses of lithium should have “tangible beneficial effects” at the early stages of the disease.

Of course, the treatment needs to be tested on humans in clinical trials first, but all signs point to micro-lithium as being the Alzheimer’s medicine of the future.

Stay tuned.